Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000272754 | SCV000333103 | uncertain significance | not provided | 2015-07-29 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000825844 | SCV000967327 | likely benign | not specified | 2018-10-10 | criteria provided, single submitter | clinical testing | The p.Phe883Phe variant in TTN is classified as likely benign because it does no t alter an amino acid residue, is not located within the splice consensus site, and computational splice prediction tools do not predict an impact on splicing. It has been identified in 4/245924 of chromosomes by gnomAD (http://gnomad.broad institute.org). ACMG/AMP Criteria applied: BP4, BP7. |
Labcorp Genetics |
RCV001503592 | SCV001708448 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429214 | SCV002742518 | likely benign | Cardiovascular phenotype | 2021-05-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000272754 | SCV003824822 | uncertain significance | not provided | 2019-07-10 | criteria provided, single submitter | clinical testing |